These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002-2020. Castillo-Carniglia A, Rivera-Aguirre A, Santaella-Tenorio J, Fink DS, Crystal S, Ponicki W, Gruenewald P, Martins SS, Keyes KM, Cerdá M. Epidemiology; 2023 Jul 01; 34(4):467-475. PubMed ID: 36943813 [Abstract] [Full Text] [Related]
7. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Shi Y, Liang D, Bao Y, An R, Wallace MS, Grant I. Drug Alcohol Depend; 2019 Jan 01; 194():13-19. PubMed ID: 30390550 [Abstract] [Full Text] [Related]
8. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018. Lee B, Zhao W, Yang KC, Ahn YY, Perry BL. JAMA Netw Open; 2021 Feb 01; 4(2):e2036687. PubMed ID: 33576816 [Abstract] [Full Text] [Related]
9. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. JAMA Intern Med; 2014 Oct 01; 174(10):1668-73. PubMed ID: 25154332 [Abstract] [Full Text] [Related]
10. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study. Hsu G, Kovács B. BMJ; 2021 Jan 27; 372():m4957. PubMed ID: 33504472 [Abstract] [Full Text] [Related]
11. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. JAMA Intern Med; 2018 May 01; 178(5):667-672. PubMed ID: 29610897 [Abstract] [Full Text] [Related]
13. Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders. Bradford AC, Lozano-Rojas F, Shone HB, Bradford WD, Abraham AJ. JAMA Netw Open; 2024 Sep 03; 7(9):e2432021. PubMed ID: 39235808 [Abstract] [Full Text] [Related]
14. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic. Bleyer A, Barnes B, Finn K. J Opioid Manag; 2024 Sep 03; 20(2):119-132. PubMed ID: 38700393 [Abstract] [Full Text] [Related]
15. Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017. Santaella-Tenorio J, Wheeler-Martin K, DiMaggio CJ, Castillo-Carniglia A, Keyes KM, Hasin D, Cerdá M. JAMA Intern Med; 2020 Aug 01; 180(8):1061-1068. PubMed ID: 32568378 [Abstract] [Full Text] [Related]
16. Association of Recreational Cannabis Legalization With Maternal Cannabis Use in the Preconception, Prenatal, and Postpartum Periods. Skelton KR, Hecht AA, Benjamin-Neelon SE. JAMA Netw Open; 2021 Feb 01; 4(2):e210138. PubMed ID: 33630088 [Abstract] [Full Text] [Related]
19. Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011. Kim JH, Martins SS, Shmulewitz D, Hasin D. Int J Drug Policy; 2022 Jan 01; 99():103449. PubMed ID: 34587580 [Abstract] [Full Text] [Related]
20. Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy. Lo SY, Winston-McPherson GN, Starosta AJ, Sullivan MD, Baird GS, Hoofnagle AN, Greene DN. Am J Med; 2019 Mar 01; 132(3):347-353. PubMed ID: 30419224 [Abstract] [Full Text] [Related] Page: [Next] [New Search]